Recently, Beckman Coulter Life Sciences and Tools Biotech jointly held a seminar titled "The New Chapter of mRNA: Unlocking the Potential of Gene Medicine." The event featured speakers including Tsuimin Tsai, Chairman and General Manager of FormuRx Pharmaceuticals, Eylot Lam, Field Application Scientist at Beckman Coulter Life Sciences, Guanyin Shen, Senior Researcher at Croyez Bioscience, and Professor Ji-Gang Zeng from the Department of Microbiology and Immunology at National Taiwan University College of Medicine. They shared insights into the crucial role of mRNA therapy in drug development and practical experiences in optimizing processes and scaling up production.

Original Source from Global Bio & Investment